Lipid measures are associated with cognitive functioning in multiple sclerosis patients.

Area of Science:

• Neuroimmunology
• Neuroscience
• Metabolic disorders

Background:

• Cognitive decline is a significant issue in multiple sclerosis (MS).
• Previous research suggests a potential link between lipid metabolism and cognitive function in MS patients.

Purpose of the Study:

• To investigate the relationship between lipid profiles and cognitive performance in a large cohort of MS patients.
• To determine if lipid measures predict cognitive decline over time in MS.

Main Methods:

• Analysis of lipid profiles and cognitive test scores from 211 MS patients.
• Utilized Spearman rank correlation for baseline data and linear mixed models for repeated measures.
• Adjusted for relevant covariates including age, sex, disease-modifying therapy, and depression.

Main Results:

• Higher low-density lipoprotein cholesterol (LDL-C) correlated with lower scores on verbal learning and memory tests (CVLT, BVMT-R).
• Higher high-density lipoprotein cholesterol (HDL-C) correlated with lower scores on processing speed and auditory-verbal memory tests (SDMT, PASAT-3).
• These associations remained significant after adjusting for disability and brain volume.

Conclusions:

• Dyslipidemia appears to have a mild negative impact on cognitive performance in MS patients.
• Lipid management may play a role in mitigating cognitive decline in MS, independent of brain atrophy.